Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Acta Biomater. 2013 Aug 2;10(4):1588–1600. doi: 10.1016/j.actbio.2013.07.031

Fig. 6.

Fig. 6

Intracellular delivery of reducible heparin nanogels for apoptotic cell death. i) Synthetic scheme of disulfide crosslinked heparin nanogels. ii) (A) Dose-dependent anti-proliferative effect of heparin nanogels against mouse melanoma B16F10 cells after 3 days; (B) Growth profiles of B16F10 cells cultured in the presence of heparin or heparin nanogels. Reprinted with permission from [114], copyright (2008) Elsevier.